Abiopharma

Servier projette dacquérir lactivité dystrophie musculaire dEdgewise Therapeutics USA - Français USA - English USA - English

Abeona Therapeutics® Announces New Employee Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)

Sidus Space Expected Russell Index Inclusion Reflects Continued Execution of Growth and Commercialization Strategy

U.S. Army Testing Shows Iperionx Titanium Fasteners Exceed Grade 8 Steel Torque-To-Yield Performance

NYSE: MMA Investor and Strategic Advisor Conor McGregor’s UFC Return Sparks Ticket Frenzy Ahead of July 11 in Las Vegas

Cosmos Health Enters $69 Billion Global Animal Health Industry with Veterinary C-Scrub Wash 4% Following Successful European Standard Testing Under EN 1656 and EN 1657

Janus Living Announces Launch of Public Offering of Class A-1 Common Stock

NiCE World 2026: taking place on June 8-10th - Where Agentic AI Meets Enterprise Scale-PR

Vaxart Files Definitive Proxy Statement and Mails Letter to Shareholders

Greenwich LifeSciences Presents FLAMINGO-01 Phase III Trial Open Label Data Published at ASCO Meeting 2026